“…MADaM (OMIM #619127) has been recently described in seven patients from five families originating from India, Turkey, Algeria, Egypt, and Ecuador, and diagnosed as a severe progeroid form of MAD with clinical features resembling HGPS, including small viscerocranium with mandibular underdevelopment, growth retardation, lipodystrophy, altered skin pigmentation, distal acro-osteolyses, renal focal glomerulosclerosis, and severe cardiovascular disease, but all showing normal cognitive development. 40 Patients were first screened for pathogenic mutations in the LMNA, ZMPSTE24, BANF1 , and POLD1 genes, but none was found. 40 Subsequent NGS approaches in affected members of these families revealed five pathogenic recessive mutations in MTX2 , and particularly a c.2T>A missense mutation (p.Met1Lys) in the first family, a c.544–1G>C base substitution within the splice acceptor site in intron 8 in the second family and a c.208+3_208+6del within the splice donor site in intron 4 in the third family, both leading to altered mRNAs resulting in premature termination codons in the protein (respectively, p.Val182Argfs*3 and p.Ala46Valfs*12), a frame-shift mutation in exon 9 in the fourth family (c.603del; p.Tyr202Ilefs*26), and a homozygous 2-bp deletion in exon 6 (c.294_295delTC) resulting in a nonsense mutation (p.Leu99*) in the fifth family.…”